| 000 | 01769 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516081321.0 | ||
| 264 | 0 | _c20121002 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1560-7917 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZagorianou, A | |
| 245 | 0 | 0 |
_aMicrobiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. _h[electronic resource] |
| 260 |
_bEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin _cFeb 2012 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacterial Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aBacterial Typing Techniques |
| 650 | 0 | 4 | _aDrug Resistance, Multiple, Bacterial |
| 650 | 0 | 4 | _aEndemic Diseases |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Amplification |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGreece _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKlebsiella Infections _xdrug therapy |
| 650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 |
_abeta-Lactamases _xbiosynthesis |
| 650 | 0 | 4 |
_abeta-Lactams _xtherapeutic use |
| 700 | 1 | _aSianou, E | |
| 700 | 1 | _aIosifidis, E | |
| 700 | 1 | _aDimou, V | |
| 700 | 1 | _aProtonotariou, E | |
| 700 | 1 | _aMiyakis, S | |
| 700 | 1 | _aRoilides, E | |
| 700 | 1 | _aSofianou, D | |
| 773 | 0 |
_tEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin _gvol. 17 _gno. 7 |
|
| 999 |
_c21578860 _d21578860 |
||